Lecturer in Precision Medicine at the Patrick G. Johnson Centre for Cancer Research, Queen's University Belfast
BIOGRAPHY
Speaker
Event Date & Time
Date: January 20, 2022
Time: 08:00am (PST), 11:00am (EST), 5:00pm (CET)
Abstract
Automated staining platforms and digital slide scanners have revolutionized tissue-based biomarker research by providing a powerful platform in which to conduct reproducible, quantitative biomarker-led studies at scale. Use of machine learning and artificial intelligence approaches to analyze these biomarkers enables sensitive, specific and rapid biomarker assessment in situ. In this talk, we will be reviewing the implementation and technical challenges faced in modern tissue-based, biomarker-led research from wet-lab validation to digital assessment. To do so we will review published work from our lab that has utilized automated staining and slide digitization as an aid to clinical research (for research use only. Not for use in diagnostic procedures) in immunohistochemistry, RNA in situ hybridization, multiplex immunofluorescence and artificial intelligence studies.
Learning Objectives
- Learn how automated staining and slide digitization can reduce staining variability and aid in quantitative biomarker assessment at scale
- Understand how digitization of molecular pathology assessment lends itself to multi- and cross-disciplinary research investigations
For Research Use Only. Not for Use in Diagnostic Procedures
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...